iSOFT Wins 2010 European Business Analytics Systems Competitive Strategy Leadership Award

iSOFTiSOFT Group Limited, one of the world's largest healthcare information technology companies, has received the Frost and Sullivan, 2010 European Business Analytics Systems Competitive Strategy Leadership Award.

HiNT is a powerful business analytics tool designed to empower modern healthcare organisations with business-critical information. By consolidating data from all the various applications within an organisation, users can view and explore information, trends and performance indicators covering all aspects of service delivery and financial performance. Designed around the latest clinical coding standards and with prebuilt reporting dashboards covering clinical activity, administration, finance and performance, Health Intelligence was seen as the market leader by Frost & Sullivan, and the clear winner for this award.

For the Competitive Strategy Leadership Award, the following criteria were used to benchmark iSOFT's performance against key competitors:

  • Leverage of competitive intelligence
  • Execution of competitive strategy
  • Impact on market share
  • Competitive brand positioning (brand strength and unique market position)
  • Impact on customer satisfaction/value

Through the overall product strategy, management and marketing, this award recognises iSOFT's growing market share and ongoing commitment to the healthcare sector.

The award was presented to Eamonn Morris, Managing Director of iSOFT Business Solutions, at a gala awards dinner in London on 19 May. Eamonn Morris said: "This is a significant achievement for iSOFT and illustrates the power and uniqueness of the iSOFT Health Intelligence solution, HiNT. Since taking the solution to market in late 2009, we have seen a huge interest from clients, prospects and partners in all territories across the globe. At iSOFT we have a dream, which is enhancing lives through innovative healthcare solutions; HiNT is a prime example of where iSOFT have designed and developed a solution which will add value to healthcare organisations worldwide, providing administrative, financial and clinical intelligence to enable informed decisions regarding the management and delivery of healthcare."

Frost & Sullivan acknowledges iSOFT's significant investments in research and development to improve the organisation's position, commenting, "iSOFT places more emphasis on providing user-friendly and efficient information and analytic solutions for its healthcare customers. Hundreds of hospitals have adopted iSOFT's healthcare information systems, as they offer greater return on investment."

A global network of iSOFT subsidiaries and partner networks provides significant support to the national healthcare markets, offering customers a complete suite of solutions and services around the world.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organizations.

Today, more than 13,000 provider organizations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

About Frost and Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit www.frost.com.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...